IPO Timeline
Broker Results (T-2)
2021-11-03
Some brokers release in afternoon
Grey Market (T-1)
2021-11-04
Afternoon
HKEX Allotment (T-1)
2021-11-04
Evening
Registrar Allotment (T-1)
2021-11-04
Evening
Listing Day (T)
2021-11-05
First day of trading
Company Overview
| Stock Name | 北京鷹瞳科技發展股份有限公司 - B - H股 |
|---|---|
| Stock Code | 02251 |
| Company Full Name | 北京鷹瞳科技發展股份有限公司 - B - H股 |
| Industry | 醫療保健 |
| Principal Activities | 主要在中國從事提供人工智能視網膜影像識別的早期檢測、診斷及健康風險評估解決方案，包括用於檢測及診斷的人工智能醫療器械軟件、健康風險評估解決方案及硬件設備。 |
| Listing Date | 2021-11-05 |
| Listing Rules Era | Old Rules |
| Listing Rules Chapter | To be extracted |
| Weighted Voting Rights (WVR) | No |
| Registered Address (Mainland China) | 中國北京市海淀區西三環北路甲2號院2號樓4層21室 |
| Business Address (Hong Kong) | To be extracted |
| Place of Incorporation | To be extracted |
| Listing Method | To be extracted |
| Listing Board | Main Board |
| Website | https://www.airdoc.com |
| Share Registrar | 卓佳证券登记有限公司 (Tricor Investor Services Limited) |
| Registrar Contact | (852)2980 1333 |
| A-Share/US Dual Listing | No data |
Offering Information
| Offering Mechanism | To be extracted |
|---|---|
| Offer Price | HK$ 75.10 / shares |
| Offer Price Range | To be extracted |
| Lot Size | To be extracted |
| Entry Threshold | To be extracted |
| Par Value | To be extracted |
| Offer Period | To be extracted |
| Global Offering Shares | To be extracted |
| HK Public Offer Shares (Initial) | To be extracted |
| Public Offer Lots (Initial) | To be extracted |
| International Placing Shares (Initial) | To be extracted |
| Offer Ratio | To be extracted |
| Total Shares Post-IPO | To be extracted |
| Greenshoe (Over-allotment Option) | To be confirmed |
| Stabilizing Manager (Greenshoe) | — |
| Cornerstone Share | 32.5% |
| Clawback Tiers | To be extracted |
| Reallocation Option | To be confirmed |
| Total Global Offering Size | HK$ 167,232,680 |
Valuation & Financials
| Market Cap (at Offer Price) | To be extracted |
|---|---|
| Pre-IPO Valuation (Last Round) | To be extracted |
| P/E Ratio | To be extracted |
| Profit/Loss Status | To be extracted |
| Period-End Cash Balance | To be extracted |
| Listing Expenses | To be extracted |
| Listing Expenses / Funds Raised | To be extracted |
| Total Pre-IPO Investment | To be extracted |
First Day Performance
| First Day Close | HK$ 68.0 |
|---|---|
| First Day Open | HK$ 67.6 |
| First Day Change | -9.45% |
| First Day Volume | 11495800.0 |
| First Day Turnover | 792433000.0 |
Use of Proceeds
| Use of Proceeds | 1、約50.0%（或783.2百萬港元）將分配予我們的核心產品Airdoc-AIFUNDUS的持續優化、開發及商業化； 2、約19.0%（或297.6百萬港元）將用于資助我們硬件設備的研發及生產； 3、約10.0%（或156.6百萬港元）將用于資助我們正在進行的及未來的健康風險評估解決方案的研發； 4、約6.0%（或94.0百萬港元）將用于我們產品組合的開發，以豐富我們人工智能視網膜影像識別的早期檢測、診斷及健康風險評估解決方案； 5、約5.0%（或78.3百萬港元）將用于為我們與學術及研究機構就聯合研究項目進行的合作提供資金； 6、約10.0%（或156.6百萬港元）將用于營運資金及一般公司用途。 |
|---|
Underwriting Syndicate
Joint Sponsors (2)
UBS Securities Hong Kong Limited CE BIN466
中信证券（香港）有限公司 CE AAK249
Overall Coordinators (5)
UBS Securities Hong Kong Limited CE BIN466
中信里昂证券有限公司 CE AAB893
招银国际融资有限公司 CE AVM940
安信国际证券(香港)有限公司
海通国际证券有限公司 CE AAF806
Joint Bookrunners (10)
UBS Securities Hong Kong Limited CE BIN466
中信里昂证券有限公司 CE AAB893
招银国际融资有限公司 CE AVM940
安信国际证券(香港)有限公司
海通国际证券有限公司 CE AAF806
平证证券(香港)有限公司
复星国际证券有限公司 CE AAF432
GF Securities (Hong Kong) Brokerage Limited CE AOB364
GUODU SECURITIES (HONG KONG) LIMITED CE ASK641
浦银国际融资有限公司 CE BFZ375
Joint Lead Managers (10)
UBS Securities Hong Kong Limited CE BIN466
中信里昂证券有限公司 CE AAB893
招银国际融资有限公司 CE AVM940
安信国际证券(香港)有限公司
海通国际证券有限公司 CE AAF806
平证证券(香港)有限公司
复星国际证券有限公司 CE AAF432
GF Securities (Hong Kong) Brokerage Limited CE AOB364
GUODU SECURITIES (HONG KONG) LIMITED CE ASK641
浦银国际融资有限公司 CE BFZ375
Cornerstone Investors
| # | Investor Name | Investment Amount | Shares Subscribed | % of Offer Shares | % of Total Shares | Lock-up Period | Est. Unlock Date |
|---|---|---|---|---|---|---|---|
| 1 | CloudAlpha Master Fund | 116,682,870 HKD | — | 7.00% | — | 6 months | 2022-05-05 |
| 2 | Lake Bleu Prime Healthcare Master Fund Limited | 38,894,290 HKD | — | 2.30% | — | 6 months | 2022-05-05 |
| 3 | LAV Star Limited | 77,788,580 HKD | — | 4.70% | — | 6 months | 2022-05-05 |
| 4 | LMR Master Fund Limited | 58,337,680 HKD | — | 3.50% | — | 6 months | 2022-05-05 |
| 5 | OrbiMed Funds | 38,894,290 HKD | — | 2.30% | — | 6 months | 2022-05-05 |
| 6 | WT Asset Management Limited | 77,788,580 HKD | — | 4.70% | — | 6 months | 2022-05-05 |
| 7 | 常春藤资产管理(香港)有限公司 | 54,447,500 HKD | — | 3.30% | — | 6 months | 2022-05-05 |
| 8 | 广发基金管理有限公司 | 77,788,580 HKD | — | 4.70% | — | 6 months | 2022-05-05 |
Directors & Management
| Chairman | 張大磊 |
|---|---|
| Company Secretary | 王新鳳;蘇麗珊 |
No director data available.
Major Shareholders
| Major Shareholders & Holdings | 張大磊及關連人士(21.8%);亞東北辰創業投資有限公司(9.92%);平安科技(深圳)有限公司(6.92%);徐彥華及關連人士(6.26%);騰訊控股有限公司(5.74%) |
|---|
IPO Timeline
